FBInvestor
Stocks / Ligand Pharmaceuticals Inc Con
Institutional Ownership

Ligand Pharmaceuticals Inc Con

CUSIP 532CNT029COMQ1 2026

Earnings

Quarterly EPS and revenue are sourced from SEC XBRL financial statements. We ingest the top issuers first; this fills in as coverage expands (or this security isn't mapped to an SEC filer yet).

Coming soon